Clinical Trial Update: To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of duloxetine in patients with stress urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Duloxetine (Cymbalta) (Duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Stress Urinary Incontinence | Phase 3 | Status: COMPLETED